ASXC News and Press, Asensus Surgical Inc Com From 05/11/22

Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H. C. Wainwright Global Investment Conference in Miami, Florida. The Company’s fireside chat will take place on T...

Asensus Surgical Inc. (ASXC) Q1 2022 Earnings Conference Call May 4, 2022 16:30 ET Company Participants Mark Klausner - Westwicke Partners, Investor Relations Anthony Fernando - President & Chief Executive Officer Shameze Rampertab - Executive Vice President & Chief Financial Officer ...

Shares of Asensus Surgical (NYSE:ASXC) fell 4% in after-hours trading after reporting Q1 2022 revenue that fell below consensus estimates. Net loss widened ~10% year over year to $19.1M, but still beat consensus. Revenue of ~$1.07M in the quarter was a ~49% drop from Q1 2021. Revenu...

Asensus Surgical press release (NYSE:ASXC): Q1 Non-GAAP EPS of -$0.07 beats by $0.01. Revenue of $1.07M (-48.6% Y/Y) misses by $0.23M. The Company had cash, cash equivalents, short-term and long-term investments, excluding restricted cash, of approximately $118.5 million at March 31, 2022. Du...

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the first quarter 2022. R...

Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022 first quarter financial and operating re...

Asensus Surgical is leading the digital surgical market with Performance-Guided Surgery(TM) New York, New York--(Newsfile Corp. - April 20, 2022) - PCG Digital -- Surgery can be unpredictable, and a staggering one in five patients undergoing surgery has one, or even multiple, preventable surg...

Asensus Surgical (NYSE:ASXC) has filed for a $150M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company intends to use the proceeds for working capital and general corporate purposes, including R&D, commerciali...

Asensus Surgical Inc. (ASXC) Q4 2021 Results Conference Call February 28, 2022 4:30 PM ET Company Participants Anthony Fernando - CEO Shameze Rampertab - CFO Conference Call Participants Mark Klausner - Westwicke Swayampakula Ramakanth - H.C. Wainwright Ross Osborn - Cantor Fitzgerald Present...

Asensus Surgical press release (NYSE:ASXC): Q4 Non-GAAP EPS of -$0.07. Revenue of $2.48M (+123.4% Y/Y). Shares +2%. For further details see: Asensus Surgical Non-GAAP EPS of -$0.07, revenue of $2.48M